Search Results

Search

Ethics Talk: Unblinding COVID-19 Vaccine Trials

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Steven Goodman about the ethical and scientific implications of unblinding COVID-19 vaccine trials.

Click here to read the transcript.

Steven Goodman, MD, MHS, PhD is Associate Dean of Clinical and Translational Research and Professor of Medicine and of Epidemiology and Population Health at Stanford School of Medicine.

Video

 

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Legacies of the Holocaust in Health Care CME Off

Ethics Talk: Public, Civic and Spiritual Health During COVID

Submitted by Audiey.Kao@ama… on

In this video and podcast edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Patrick Smith about intersections of public health, civic good and spiritual well-being during this COVID-19 pandemic. 

Click here to read the transcript. 

Patrick Smith, PhD, MA, MDiv is associate research professor of theological ethics and bioethics at the Duke Divinity School, senior fellow at the Kenan Institute for Ethics at Duke University, and core faculty with the Trent Center for Bioethics, Humanities, and History of Medicine at Duke University School of Medicine. 

Video

Recorded on April 23, 2021

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Compassionate Force CME Off

Ethics Talk: Equity and Intellectual Property Protection of COVID Vaccines

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Prof Ana Santos Rutschman about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Click here to read the transcript. 

Ana Santos Rutschman, SJD is an assistant professor of law at the Saint Louis University School of Law.

Video

Recorded on April 28, 2021

 

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Ending the HIV Epidemic CME Off
Original Research
Oct 2018

Produce Rx Programs for Diet-Based Chronic Disease Prevention

Haley Swartz, MPP
Produce prescription programs can expand patient's food choices and provide financial incentives to change consumption behaviors. If these programs are not linked to established government assistance programs, however, growers could be at risks for bearing the cost.
AMA J Ethics. 2018;20(10):E960-973. doi: 10.1001/amajethics.2018.960
Policy Forum
Oct 2018

What Lies Behind the Transition From Plant-Based to Animal Protein?

Adam Drewnowski, PhD and Jean-Pierre Poulain, PhD
Sociocultural and economic factors drive transition from plant-based to animal-based protein sources in rapidly developing and urbanizing countries of South Asia and Southeast Asia. Better understanding the health impact of this transition requires integrating epidemiological and social science research methods.
AMA J Ethics. 2018;20(10):E987-993. doi: 10.1001/amajethics.2018.987.
Medical Education
Sep 2019

How Should Schools Respond to Learners’ Demands for Global Health Training?

Claudia O. Gambrah-Sampaney, MD, Jesse E. Passman, MD, MPH, Andrielle Yost, MPA, and Glen N. Gaulton, PhD
In the past decade, more students than ever entered medical school with the desire, if not the expectation, of participating in meaningful global health experiences.
AMA J Ethics. 2019;21(9):E772-777. doi: 10.1001/amajethics.2019.772.
State of the Art and Science
Jan 2020

Making Emergency Use of Experimental Vaccines Safer

Archana Asundi, MD and Nahid Bhadelia, MD
How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020;22(1):E43-49. doi: 10.1001/amajethics.2020.43.
Art of Medicine
Aug 2022

Contraception Options

Michaela Chan
“Contraception Options” considers the general social and cultural expectation and norm that women’s bodies should be the sites of contraception.
AMA J Ethics. 2022;24(8):E804-805. doi: 10.1001/amajethics.2022.804.